Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Kondor, Rebecca"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-35 z 35
    Tytuł:
    Genetic and potential antigenic evolution of influenza A(H1N1)pdm09 viruses circulating in Kenya during 2009–2018 influenza seasons
    Autorzy:
    Owuor, D. CollinsAff1, IDs41598023491573_cor1
    de Laurent, Zaydah R.
    Nyawanda, Bryan O.
    Emukule, Gideon O.
    Kondor, Rebecca
    Barnes, John R.
    Nokes, D. JamesAff1, Aff5
    Agoti, Charles N.Aff1, Aff6
    Chaves, Sandra S.Aff3, Aff4
    Pokaż więcej
    Źródło:
    Scientific Reports. 13(1)
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    United States Centers for Disease Control and Prevention support for influenza surveillance, 2013-2021.
    Autorzy:
    McCarron, Margaret
    Kondor, Rebecca
    Zureick, Kinda
    Griffin, Chelsey
    Fuster, Christian
    Hammond, Aspen
    Lievre, Maja
    Vandemaele, Katelijn
    Bresee, Joseph
    Xiyan Xu
    Dugan, Vivien G.
    Weatherspoon, Vashonia
    Williams, Thelma
    Vance, April
    Fry, Alicia M.
    Samaan, Magdi
    Fitzner, Julia
    Wenqing Zhang
    Moen, Ann
    Wentworth, David E.
    Pokaż więcej
    Alternatywny tytuł:
    2021 لىإ 2013 ،ازنولفنلإا ةبقارلم اهنم ةياقولاو ضارملأا ةحفاكلم ةيكيرملأا زكارلما معد.
    Apoyo de los Centros para el Control y la Prevención de Enfermedades de Estados Unidos a la vigilancia de la gripe, 2013-2021.
    Aide apportée par les Centers for Disease Control and Prevention des États-Unis d'Amérique dans la surveillance des grippes, 2013-2021.
    Поддержка эпиднадзора за гриппом в 2013-2021 гг. со стороны центров США по контролю и профилактике заболеваний.
    美国疾病控制和预防中心 2013-2021 年间对流感监测的支持.
    Źródło:
    Bulletin of the World Health Organization. Jun2022, Vol. 100 Issue 6, p366-374. 9p.
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Genomic Surveillance for SARS-CoV-2 Variants: Circulation of Omicron Lineages - United States, January 2022-May 2023.
    Autorzy:
    Ma KC
    Shirk P
    Lambrou AS
    Hassell N
    Zheng XY
    Payne AB
    Ali AR
    Batra D
    Caravas J
    Chau R
    Cook PW
    Howard D
    Kovacs NA
    Lacek KA
    Lee JS
    MacCannell DR
    Malapati L
    Mathew S
    Mittal N
    Nagilla RR
    Parikh R
    Paul P
    Rambo-Martin BL
    Shepard SS
    Sheth M
    Wentworth DE
    Winn A
    Hall AJ
    Silk BJ
    Thornburg N
    Kondor R
    Scobie HM
    Paden CR
    Pokaż więcej
    Źródło:
    MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2023 Jun 16; Vol. 72 (24), pp. 651-656. Date of Electronic Publication: 2023 Jun 16.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    SARS-CoV-2*/genetics
    COVID-19*/epidemiology
    Humans ; Pandemics ; Genomics
    SCR Organism:
    SARS-CoV-2 variants
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Spike Gene Target Amplification in a Diagnostic Assay as a Marker for Public Health Monitoring of Emerging SARS-CoV-2 Variants - United States, November 2021-January 2023.
    Autorzy:
    Scobie HM
    Ali AR
    Shirk P
    Smith ZR
    Paul P
    Paden CR
    Hassell N
    Zheng XY
    Lambrou AS
    Kondor R
    MacCannell D
    Thornburg NJ
    Miller J
    Wentworth D
    Silk BJ
    Pokaż więcej
    Źródło:
    MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2023 Feb 03; Vol. 72 (5), pp. 125-127. Date of Electronic Publication: 2023 Feb 03.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Public Health*
    COVID-19*/epidemiology
    United States/epidemiology ; Humans ; SARS-CoV-2/genetics ; Mutation ; COVID-19 Testing
    SCR Organism:
    SARS-CoV-2 variants
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Influenza Activity and Composition of the 2022-23 Influenza Vaccine - United States, 2021-22 Season.
    Autorzy:
    Merced-Morales A; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    Daly P; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    Abd Elal AI; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    Ajayi N; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    Annan E; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    Budd A; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    Barnes J; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    Colon A; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    Cummings CN; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    Iuliano AD; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    DaSilva J; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    Dempster N; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    Garg S; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    Gubareva L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    Hawkins D; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    Howa A; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    Huang S; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    Kirby M; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    Kniss K; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    Kondor R; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    Liddell J; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    Moon S; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    Nguyen HT; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    O'Halloran A; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    Smith C; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    Stark T; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    Tastad K; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    Ujamaa D; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    Wentworth DE; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    Fry AM; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    Dugan VG; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    Brammer L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    Pokaż więcej
    Źródło:
    MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2022 Jul 22; Vol. 71 (29), pp. 913-919. Date of Electronic Publication: 2022 Jul 22.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    COVID-19*
    Influenza A Virus, H5N1 Subtype*
    Influenza Vaccines*
    Influenza, Human*/epidemiology
    Influenza, Human*/prevention & control
    Humans ; Influenza A Virus, H3N2 Subtype/genetics ; Influenza B virus/genetics ; Population Surveillance ; SARS-CoV-2 ; Seasons ; United States/epidemiology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Changes in Influenza and Other Respiratory Virus Activity During the COVID-19 Pandemic - United States, 2020-2021.
    Autorzy:
    Olsen SJ
    Winn AK
    Budd AP
    Prill MM
    Steel J
    Midgley CM
    Kniss K
    Burns E
    Rowe T
    Foust A
    Jasso G
    Merced-Morales A
    Davis CT
    Jang Y
    Jones J
    Daly P
    Gubareva L
    Barnes J
    Kondor R
    Sessions W
    Smith C
    Wentworth DE
    Garg S
    Havers FP
    Fry AM
    Hall AJ
    Brammer L
    Silk BJ
    Pokaż więcej
    Źródło:
    MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2021 Jul 23; Vol. 70 (29), pp. 1013-1019. Date of Electronic Publication: 2021 Jul 23.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Pandemics*
    COVID-19/*epidemiology
    Influenza, Human/*epidemiology
    Respiratory Tract Infections/*epidemiology
    Respiratory Tract Infections/*virology
    Humans ; United States/epidemiology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Genomic Surveillance for SARS-CoV-2 Variants Circulating in the United States, December 2020-May 2021.
    Autorzy:
    Paul P
    France AM
    Aoki Y
    Batra D
    Biggerstaff M
    Dugan V
    Galloway S
    Hall AJ
    Johansson MA
    Kondor RJ
    Halpin AL
    Lee B
    Lee JS
    Limbago B
    MacNeil A
    MacCannell D
    Paden CR
    Queen K
    Reese HE
    Retchless AC
    Slayton RB
    Steele M
    Tong S
    Walters MS
    Wentworth DE
    Silk BJ
    Pokaż więcej
    Źródło:
    MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2021 Jun 11; Vol. 70 (23), pp. 846-850. Date of Electronic Publication: 2021 Jun 11.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    COVID-19/*virology
    SARS-CoV-2/*genetics
    COVID-19/epidemiology ; Epidemiological Monitoring ; Humans ; SARS-CoV-2/isolation & purification ; United States/epidemiology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Update: Influenza Activity - United States and Worldwide, May 19-September 28, 2019, and Composition of the 2020 Southern Hemisphere Influenza Vaccine.
    Autorzy:
    Epperson S; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    Davis CT; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    Brammer L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    Abd Elal AI; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    Ajayi N; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    Barnes J; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    Budd AP; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    Burns E; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    Daly P; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    Dugan VG; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    Fry AM; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    Jang Y; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    Johnson SJ; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    Kniss K; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    Kondor R; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    Grohskopf LA; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    Gubareva L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    Merced-Morales A; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    Sessions W; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    Stevens J; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    Wentworth DE; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    Xu X; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    Jernigan D; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    Pokaż więcej
    Źródło:
    MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2019 Oct 11; Vol. 68 (40), pp. 880-884. Date of Electronic Publication: 2019 Oct 11.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Population Surveillance*
    Global Health/*statistics & numerical data
    Influenza Vaccines/*chemistry
    Influenza, Human/*epidemiology
    Drug Resistance, Viral ; Humans ; Influenza A Virus, H1N1 Subtype/drug effects ; Influenza A Virus, H1N1 Subtype/genetics ; Influenza A Virus, H1N1 Subtype/isolation & purification ; Influenza A Virus, H3N2 Subtype/drug effects ; Influenza A Virus, H3N2 Subtype/genetics ; Influenza A Virus, H3N2 Subtype/isolation & purification ; Influenza B virus/drug effects ; Influenza B virus/genetics ; Influenza B virus/isolation & purification ; Influenza, Human/virology ; Seasons ; United States/epidemiology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Update: Influenza Activity in the United States During the 2018-19 Season and Composition of the 2019-20 Influenza Vaccine.
    Autorzy:
    Xu X; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    Blanton L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    Elal AIA; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    Alabi N; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    Barnes J; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    Biggerstaff M; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    Brammer L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    Budd AP; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    Burns E; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    Cummings CN; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    Garg S; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    Kondor R; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    Gubareva L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    Kniss K; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    Nyanseor S; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    O'Halloran A; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    Rolfes M; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    Sessions W; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    Dugan VG; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    Fry AM; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    Wentworth DE; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    Stevens J; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    Jernigan D; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
    Pokaż więcej
    Źródło:
    MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2019 Jun 21; Vol. 68 (24), pp. 544-551. Date of Electronic Publication: 2019 Jun 21.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Population Surveillance*
    Influenza A Virus, H1N1 Subtype/*isolation & purification
    Influenza A Virus, H3N2 Subtype/*isolation & purification
    Influenza B virus/*isolation & purification
    Influenza, Human/*epidemiology
    Adolescent ; Adult ; Aged ; Antiviral Agents/pharmacology ; Child ; Child Mortality ; Child, Preschool ; Cost of Illness ; Drug Resistance, Viral ; Hospitalization/statistics & numerical data ; Humans ; Infant ; Infant Mortality ; Infant, Newborn ; Influenza A Virus, H1N1 Subtype/drug effects ; Influenza A Virus, H1N1 Subtype/genetics ; Influenza A Virus, H3N2 Subtype/drug effects ; Influenza A Virus, H3N2 Subtype/genetics ; Influenza B virus/drug effects ; Influenza B virus/genetics ; Influenza Vaccines/administration & dosage ; Influenza Vaccines/chemistry ; Influenza, Human/mortality ; Influenza, Human/prevention & control ; Influenza, Human/virology ; Middle Aged ; Outpatients/statistics & numerical data ; Pneumonia/mortality ; Seasons ; Severity of Illness Index ; United States/epidemiology ; Young Adult
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
      Wyświetlanie 1-35 z 35

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies